193 related articles for article (PubMed ID: 26026951)
1. A fluorescent approach for identifying P2X1 ligands.
Ruepp MD; Brozik JA; de Esch IJ; Farndale RW; Murrell-Lagnado RD; Thompson AJ
Neuropharmacology; 2015 Nov; 98():13-21. PubMed ID: 26026951
[TBL] [Abstract][Full Text] [Related]
2. P2X receptor chimeras highlight roles of the amino terminus to partial agonist efficacy, the carboxyl terminus to recovery from desensitization, and independent regulation of channel transitions.
Allsopp RC; Farmer LK; Fryatt AG; Evans RJ
J Biol Chem; 2013 Jul; 288(29):21412-21421. PubMed ID: 23740251
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of selective antagonism of the P2X1 receptor for ATP by NF449 and suramin: contribution of basic amino acids in the cysteine-rich loop.
El-Ajouz S; Ray D; Allsopp RC; Evans RJ
Br J Pharmacol; 2012 Jan; 165(2):390-400. PubMed ID: 21671897
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of P2X receptors expressed in rat pulmonary arteries.
Syed NI; Tengah A; Paul A; Kennedy C
Eur J Pharmacol; 2010 Dec; 649(1-3):342-8. PubMed ID: 20868665
[TBL] [Abstract][Full Text] [Related]
5. Use of chimeras, point mutants, and molecular modeling to map the antagonist-binding site of 4,4',4″,4‴-(carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic acid (NF449) at P2X1 receptors for ATP.
Farmer LK; Schmid R; Evans RJ
J Biol Chem; 2015 Jan; 290(3):1559-69. PubMed ID: 25425641
[TBL] [Abstract][Full Text] [Related]
6. Purinergic P2X receptors: structural models and analysis of ligand-target interaction.
Dal Ben D; Buccioni M; Lambertucci C; Marucci G; Thomas A; Volpini R
Eur J Med Chem; 2015 Jan; 89():561-80. PubMed ID: 25462266
[TBL] [Abstract][Full Text] [Related]
7. Impaired P2X1 Receptor-Mediated Adhesion in Eosinophils from Asthmatic Patients.
Wright A; Mahaut-Smith M; Symon F; Sylvius N; Ran S; Bafadhel M; Muessel M; Bradding P; Wardlaw A; Vial C
J Immunol; 2016 Jun; 196(12):4877-84. PubMed ID: 27183585
[TBL] [Abstract][Full Text] [Related]
8. Neuropharmacology of purinergic receptors in human submucous plexus: Involvement of P2X₁, P2X₂, P2X₃ channels, P2Y and A₃ metabotropic receptors in neurotransmission.
Liñán-Rico A; Wunderlich JE; Enneking JT; Tso DR; Grants I; Williams KC; Otey A; Michel K; Schemann M; Needleman B; Harzman A; Christofi FL
Neuropharmacology; 2015 Aug; 95():83-99. PubMed ID: 25724083
[TBL] [Abstract][Full Text] [Related]
9. Validation of Alexa-647-ATP as a powerful tool to study P2X receptor ligand binding and desensitization.
Bhargava Y; Nicke A; Rettinger J
Biochem Biophys Res Commun; 2013 Aug; 438(2):295-300. PubMed ID: 23896604
[TBL] [Abstract][Full Text] [Related]
10. Lipid raft association and cholesterol sensitivity of P2X1-4 receptors for ATP: chimeras and point mutants identify intracellular amino-terminal residues involved in lipid regulation of P2X1 receptors.
Allsopp RC; Lalo U; Evans RJ
J Biol Chem; 2010 Oct; 285(43):32770-32777. PubMed ID: 20699225
[TBL] [Abstract][Full Text] [Related]
11. Molecular identification of P2X receptors in vascular smooth muscle cells from rat anterior, posterior, and basilar arteries.
Harhun MI; Sukhanova K; Gordienko D; Dyskina Y
Pharmacol Rep; 2015 Dec; 67(6):1055-60. PubMed ID: 26481522
[TBL] [Abstract][Full Text] [Related]
12. P2X1 and P2X2 receptors in the central nervous system as possible drug targets.
Hausmann R; Schmalzing G
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):675-86. PubMed ID: 22963438
[TBL] [Abstract][Full Text] [Related]
13. The ATP-gated P2X
El Mdawar MB; Maître B; Magnenat S; Gachet C; Hechler B; de la Salle H
Sci Rep; 2019 Mar; 9(1):5159. PubMed ID: 30914724
[TBL] [Abstract][Full Text] [Related]
14. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, potentiates ATP-gated P2X₁ receptor channel currents.
Choi SH; Kim HJ; Kim BR; Shin TJ; Hwang SH; Lee BH; Lee SM; Rhim H; Nah SY
Mol Cells; 2013 Feb; 35(2):142-50. PubMed ID: 23456336
[TBL] [Abstract][Full Text] [Related]
15. Discovery and Structure Relationships of Salicylanilide Derivatives as Potent, Non-acidic P2X1 Receptor Antagonists.
Tian M; Abdelrahman A; Baqi Y; Fuentes E; Azazna D; Spanier C; Densborn S; Hinz S; Schmid R; Müller CE
J Med Chem; 2020 Jun; 63(11):6164-6178. PubMed ID: 32345019
[TBL] [Abstract][Full Text] [Related]
16. Tightening of the ATP-binding sites induces the opening of P2X receptor channels.
Jiang R; Taly A; Lemoine D; Martz A; Cunrath O; Grutter T
EMBO J; 2012 May; 31(9):2134-43. PubMed ID: 22473210
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic insights from resolving ligand-dependent kinetics of conformational changes at ATP-gated P2X1R ion channels.
Fryatt AG; Dayl S; Cullis PM; Schmid R; Evans RJ
Sci Rep; 2016 Sep; 6():32918. PubMed ID: 27616669
[TBL] [Abstract][Full Text] [Related]
18. Ionotropic purinergic receptor 7 (P2X7) channel structure and pharmacology provides insight regarding non-nucleotide agonism.
Al-Aqtash R; Collier DM
Channels (Austin); 2024 Dec; 18(1):2355150. PubMed ID: 38762911
[TBL] [Abstract][Full Text] [Related]
19. Purinergic control of vascular tone in the retina.
Kur J; Newman EA
J Physiol; 2014 Feb; 592(3):491-504. PubMed ID: 24277867
[TBL] [Abstract][Full Text] [Related]
20. Functional expression of P2X1, P2X4 and P2X7 purinergic receptors in human monocyte-derived macrophages.
Vargas-Martínez EM; Gómez-Coronado KS; Espinosa-Luna R; Valdez-Morales EE; Barrios-García T; Barajas-Espinosa A; Ochoa-Cortes F; Montaño LM; Barajas-López C; Guerrero-Alba R
Eur J Pharmacol; 2020 Dec; 888():173460. PubMed ID: 32805257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
